Skip to main navigation
Ardelyx logo2
  • Who We Are
  • Products
  • Science & Pipeline
  • Patients & Families
  • Medical Professionals
  • Investors
  • Join Us
  • MENU
  • HOME
Select Page

PRESS RELEASES

  • IR HOME
  • NEWS & EVENTS
    • OVERVIEW
    • PRESS RELEASES
    • EVENTS & PRESENTATIONS
  • STOCK INFORMATION
    • OVERVIEW
    • HISTORIC STOCK LOOKUP
    • INVESTMENT CALCULATOR
    • ANALYST COVERAGE
  • FINANCIALS & FILINGS
    • OVERVIEW
    • SEC FILINGS
  • CORPORATE GOVERNANCE
    • OVERVIEW
    • MANAGEMENT
    • BOARD OF DIRECTORS
    • COMMITTEE COMPOSITION
  • CONTACT IR
  • IR HOME
  • NEWS & EVENTS
    • OVERVIEW
    • PRESS RELEASES
    • EVENTS & PRESENTATIONS
  • STOCK INFORMATION
    • OVERVIEW
    • HISTORIC STOCK LOOKUP
    • INVESTMENT CALCULATOR
    • ANALYST COVERAGE
  • FINANCIALS & FILINGS
    • OVERVIEW
    • SEC FILINGS
  • CORPORATE GOVERNANCE
    • OVERVIEW
    • MANAGEMENT
    • BOARD OF DIRECTORS
    • COMMITTEE COMPOSITION
  • CONTACT IR

PRESS RELEASES

Press Releases
Date Title
Jun 8, 2020 Ardelyx Appoints Veteran Biopharma Executive, Justin Renz, as Chief Financial Officer
May 26, 2020 Ardelyx to Present at the Jefferies 2020 Virtual Healthcare Conference
May 21, 2020 Ardelyx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 18, 2020 Ardelyx Strengthens Management Team with Appointment of Susan Rodriguez as Chief Commercial Officer
May 7, 2020 Ardelyx Reports First Quarter 2020 Financial Results and Recent Business Highlights
Mar 16, 2020 Ardelyx Appoints Onaiza Cadoret-Manier to its Board of Directors
Mar 6, 2020 Ardelyx Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Highlights
Feb 26, 2020 Ardelyx to Present at the Cowen and Company 40th Annual Health Care Conference
Feb 19, 2020 Ardelyx to Present at the 9th Annual SVB Leerink Global Healthcare Conference
Dec 4, 2019 Ardelyx Announces Pricing of Upsized Public Offering of Common Stock

Pagination

  • First page « first
  • Previous page ‹ previous
  • …
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Current page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • …
  • Next page next ›
  • Last page last »
FAQs
Email Alerts
Connect

Bay Area
34175 Ardenwood Boulevard
Fremont, CA 94555

Greater Boston
400 Fifth Avenue, Suite 210
Waltham, MA 02451

Phone: 617.675.ARDX (2739)

Inquiries:
General: info@ardelyx.com
Media: media@ardelyx.com
Investor: investor@ardelyx.com
Business Development: partnering@ardelyx.com

  • Follow
  • Follow

© 2023 Ardelyx®
Terms & Conditions · Privacy Policy
Expanded Access · Forward Looking Statements

SITE DESIGN BY D&CO
  • Facebook
  • LinkedIn
  • Twitter
  • RSS